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SUMMARY
HIV spread in men who have sex with men (MSM) is an increasing problem in Poland. Despite
the existence of a surveillance system, there is no direct evidence to allow estimation of HIV
prevalence and the proportion undiagnosed in MSM. We extracted data on HIV and the MSM
population in Poland, including case-based surveillance data, diagnostic testing prevalence data
and behavioural data relating to self-reported prior diagnosis, stratified by age (435, >35 years)
and region (Mazowieckie including the capital city of Warsaw; other regions). They were
integrated into one model based on a Bayesian evidence synthesis approach. The posterior
distributions for HIV prevalence and the undiagnosed fraction were estimated by Markov Chain
Monte Carlo methods. To improve the model fit we repeated the analysis, introducing bias
parameters to account for potential lack of representativeness in data. By placing additional
constraints on bias parameters we obtained precisely identified estimates. This family of models
indicates a high undiagnosed fraction [68·3%, 95% credibility interval (CrI) 53·9–76·1] and overall
low prevalence (2·3%, 95% CrI 1·4–4·1) of HIV in MSM. Additional data are necessary in order
to produce more robust epidemiological estimates. More effort is urgently needed to ensure
timely diagnosis of HIV in Poland.
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INTRODUCTION
Men who have sex with men (MSM) are at present
one of the groups most vulnerable to experiencing
HIV outbreaks. After a decline of drug-injection-
related epidemics in Europe and North America as a
consequence of implementing intense harm-reduction
measures, many countries are now seeing a re-
emergence of sexually transmitted HIV, especially in
MSM [1, 2].
There is also growing evidence that HIV has be-
come an important public health issue in MSM in
Poland [3]. An increase in the number of new diagno-
ses in this group was observed after 2005–2006, but it
is not clear to what extent this tendency may be
related to wider testing of a largely undiagnosed
pool of infected MSM and to what extent it represents
a trend in newly acquired infections. In many coun-
tries, the MSM population is targeted for extensive
screening [4] and new technologies are being investi-
gated to further scale up screening [5–8]. High
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coverage of such screening is necessary to fully benefit
from potential incidence reduction due to early treat-
ment [9], as undiagnosed infections pose a serious
public health concern. First, they can contribute to
increased morbidity and treatment costs of advanced-
stage infections. It has been estimated that late presen-
tation, especially with initial CD4 counts <100 cells/
mm3, causes a substantial increase in direct medical
costs of HIV care [10, 11]. Second, undiagnosed infec-
tions may drive the (re-)emergence of the HIV epi-
demic. Understanding the extent of HIV spread, the
prevalence, as well as the proportion of infected peo-
ple who are undiagnosed, may help inform the plan-
ning and evaluation of testing strategies, as well as
the prediction of the future burden of disease and con-
sequent treatment needs.
Although HIV testing is promoted in MSM in
Poland, the proportion of infections that are undiag-
nosed remains largely unknown. Despite clear evi-
dence of HIV spread in MSM in Poland during
recent years, the most recent seroprevalence study
was conducted in 2004, in 12 cities in Poland, reveal-
ing a prevalence of 4·7%; about 40% of infections in
the study were still undiagnosed [12]. Since then, esti-
mation of HIV prevalence in this group in Poland has
not been attempted. Although several data sources
exist, they do not allow direct estimation of either
the prevalence or the diagnosed fraction. They include
diagnostic testing data, self-reported behavioural data
and data originating from case-based surveillance of
diagnosed infections. Moreover, the quality of the in-
formation provided remains problematic. The surveil-
lance data suffer from underreporting of the exposure
category and possible misclassification of MSM to
other exposure categories, due to reservations in dis-
closing MSM status [3]. The survey data, on the
other hand, are often based on convenience sampling
or rely on volunteers. Although sampling method-
ology for hard-to-reach populations, such as MSM,
has recently improved, many challenges still remain
[13]. In consequence, it is often difficult to determine
if the study sample is representative for the overall
population of MSM, as well as to understand poten-
tial biases. These challenges preclude the use of direct
estimation methods [14]. However, it is still possible to
estimate the main parameters of interest, such as HIV
prevalence, by combining imperfect and indirectly
related data sources. Understanding how these data
are collected allows explicit definition of the quantities
measured by them in terms of functions of the main
parameters of interest, such as prevalence and the
undiagnosed fraction. All data sources may be then
combined into one stochastic model described in
terms of these main parameters (‘evidence synthesis’).
Importantly, this indirect method offers also the pos-
sibility of detecting conflicts between data sources
and adjusting for possible biases [15].
The aim of this study is to combine existing evi-
dence to estimate HIV prevalence and the proportion
of infections that are undiagnosed in MSM, possibly
adjusting for biases in different data sources.
METHODS
Bayesian evidence synthesis
Bayesian multi-parameter evidence synthesis (e.g. [16–
19]) was chosen as a flexible tool to combine available
data and prior knowledge. This method, as applied to
HIV, was first developed in the UK and then success-
fully implemented in other countries [20–22]. We note
that in Poland the data sources are not as abundant as
in the previously mentioned examples, and thus a fre-
quentist evidence synthesis method could be also con-
sidered. However, selecting a Bayesian approach
offers greater flexibility to expand the model should
other data become available, as well as to explicitly
introduce expert opinion [23]. The Bayesian frame-
work consists of defining a prior distribution, f(θ), de-
scribing what is known about the parameters θ of a
model before seeing the data Y; updating the prior
with the likelihood f (Y|θ) of the data given the par-
ameters; and therefore obtaining a posterior distribu-
tion, f (θ|Y)/ f (Y|θ)f (θ), for the parameters that
synthesize the prior knowledge with the observed
data [24]. In our model, we consider the basic par-
ameters of interest to be: the proportion of MSM in
males in Poland (ν); prevalence of HIV (π); and the
fraction (δ) of HIV infections in MSM in Poland
that are diagnosed. Knowing these quantities, we are
able to estimate the number of MSM who are diag-
nosed with HIV (Nνπδ, where N is the total number
of men in Poland), as well as the number of those
who are infected but are, as yet, undiagnosed (Nνπ
(1− δ)). Although direct information on the desired
parameters in Poland does not exist, there are numer-
ous data items which can be described as realizations
of distributions determined by parameters that are
functions of the basic parameters. For example, the
frequency of positive results in diagnostic testing
data may be thought to represent the prevalence of
previously undiagnosed infection and hence be
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expressed in terms of prevalence and the undiagnosed
fraction: π × (1− δ). Full model details are given in the
‘Initial model’ section below.
The joint posterior distribution for the basic par-
ameters and their marginal distributions are estimated
using a Markov Chain Monte Carlo (MCMC)
algorithm in OpenBUGS [25]. The convergence of
the algorithm was inspected visually and with the
Brooks–Gelman–Rubin statistic. Median values and
95% credibility intervals (CrI) from the posterior dis-
tribution are presented.
Model criticism
With the complexity of the models considered, assess-
ment of model fit and choosing between competing
models is critical. We used deviance summaries to as-
sess and compare models [26, 27]. The contribution to
posterior expected deviance of each data point is com-
pared to 1 to explore the goodness of fit of a specific
model to the data. To discriminate between different
models, we used the Deviance Information Criterion
(DIC). The DIC is analogous to Akaike’s Information
Criterion, used in frequentist analysis, in that it com-
bines a measure of goodness of fit, posterior mean de-
viance, with a penalty for the model complexity in the
form of the effective number of parameters. To com-
pare models including partially different datasets we
used summed contributions to the DIC for the com-
mon data points. Further details of methods are
given in the Supplementary material.
Data sources and their limitations
Case-based reporting of diagnosed cases
Case reporting was implemented in 1986 (the first
cases diagnosed in Poland in 1985 were included). It
is based mainly on reports from laboratories perform-
ing confirmatory assays, although clinicians are also
mandated to report cases that they diagnose. HIV
diagnosis can be made through voluntary testing, ei-
ther at counselling sites (often not involving clinicians)
or directly at private laboratories (upon request of an
individual). These cases might be reported by clini-
cians only when they present for care. Important in-
formation such as transmission category or clinical
status at diagnosis is often missing for new HIV diag-
noses reported only by laboratories. The EU case
definition is followed, which includes only confirmed
HIV diagnoses. A name-based identifier is used to ex-
clude duplicates at regional and national levels.
However, this identifier may be deleted from the re-
port by request of the HIV-infected person. Deaths
of persons who develop AIDS are also reportable, al-
though death reporting may be incomplete. The cen-
tral registry is maintained at the Department of
Epidemiology of the National Institute of Public
Health, National Institute of Hygiene. For this
study, we extracted data on all cases diagnosed by
31 December 2009, reported by 30 June 2013 and
not known to be dead by 31 December 2009. We
restricted the data set to male cases only, including
those reported as MSM and those with transmission
category missing.
Data from voluntary counselling and testing (VCT)
sites
The VCT network provides a sentinel system for char-
acterization of testing patterns and frequency of new
diagnoses in testers. There were 30 centres included
in the network in 2010 in major cities in Poland,
located in different institutions, including medical
facilities, public health authorities and Non-
Governmental Organizations. To ensure quality of
service and data collection, the consultants are trained
to follow the same procedure by the National AIDS
Centre. VCT sites offer free-of-charge testing accom-
panied by pre- and post-test consultation with a
trained advisor. The sites are accessible to everyone
and do not specifically encourage any particular
demographic group or HIV-affected subpopulation
to come forward for testing, although testing based
on higher levels of risky behaviours is promoted. At
presentation for testing, a consultant performs indi-
vidual risk assessment for each person requesting an
HIV test, and completes a structured questionnaire,
which is then forwarded to the National AIDS
Centre for yearly processing. The questionnaire
includes basic demographic and risk information, as
well as HIV test results. The questionnaire is anonym-
ous and possible duplicates are not excluded. A data-
set of all MSM attending any of the VCT sites in 2010
was made available by the National AIDS Centre.
This dataset was restricted to exclude records of cli-
ents who were not tested, those previously known to
be HIV positive and those of clients who reported
having already attended a VCT site in 2010 to avoid
double counting. Although data on all clients of the
VCT network were included in the analysis, the repre-
sentativeness of this group for the total population of
MSM in Poland could be questioned. First, the VCT
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sites are located in large cities and they reach a pre-
dominantly urban population. Travel distance may
be a barrier for smaller cities and villages. Second,
the VCT sites rely on volunteers who self-refer for test-
ing. This population may differ in terms of risk beha-
viours and socioeconomic characteristics, e.g.
educational status, from the general population of
MSM. The network is, in fact, promoted especially
to attract persons with higher levels of risk behaviours
(The National HIV/AIDS Programme, 2012–2016).
Behavioural and demographic data
Summary data by age and region from an internet be-
havioural survey (the European MSM Internet
Survey; EMIS) were available from the National
AIDS Centre. EMIS is a self-reported online survey
run simultaneously in 25 languages in Europe in
June–August 2010. Potential respondents were invited
through individual messages from online social net-
works or through banners on (country-specific) web-
sites (www.emis-project.eu). Additional information
can be found in [28]. EMIS was based on a conveni-
ence sample and consequently could be prone to
biases. By comparison to other data sources, biases
have been identified with respect to age and frequency
of HIV diagnoses [29].
Additionally, data from a household survey, with a
self-administered questionnaire on sexual behaviours,
were used to inform the prevalence of MSM (any sex-
ual contact with another man in his lifetime) in the
general population. The survey was implemented in
2001 among persons aged 15–49 years [30].
The source population size was extracted from cen-
sus data available at www.stat.gov.pl.
Initial model
The different data sources may overlap in terms of the
individuals included: the new diagnoses established in
VCT in 2010 may also be reported to surveillance, i.e.
may appear in the cumulative number diagnosed to
end of 2010. Individuals participating in EMIS in
2010 may also appear either in the VCT or surveillance
data. However, it is not possible to identify the over-
laps between sources, and hence to model them
dependently. To proceed, we therefore assumed inde-
pendence between data sources, while aiming to min-
imize the overlaps, by carrying out estimation for the
end of 2009, in men aged518 years. First, we use the
cumulative diagnoses observed in surveillance up to
the end of 2009 only, excluding diagnoses made in
2010. Second, we use the VCT and EMIS data in
2010 to represent, respectively, undiagnosed and diag-
nosed prevalence at the end of 2009, as explained in
the following section.
We subdivided the population into the capital city
of Warsaw and surroundings (approximated by the
Mazowieckie region, designated ‘Maz’) and the rest
of Poland (designated ‘Oth’). This categorization
may be especially relevant for HIV, as over the course
of the past decade, the number of new HIV diagnoses
displayed the greatest dynamics in the Mazowieckie
region [3]. We also included stratification into younger
(years4 35) and older (>35 years) men.
Consequently, we defined nine basic parameters:
πage,reg, the HIV prevalence by age group and region;
δage,reg, the proportion diagnosed by age group and re-
gion; and ν, the proportion of MSM in the general
male population, assumed to be the same across age
groups and regions. Each of these parameters were
given independent flat prior distributions giving
equal probability to each value in [0, 1], i.e.
πage,reg, δage,reg, νUniform[0, 1].
Likelihood contributions
Data sources informing particular parameters are pre-
sented in Table 1 and are described below.
Undiagnosed prevalence by age and region
The VCT (testing) data represent aggregated values
over a period of time of a single year, 2010. The per-
cent of tests resulting in new diagnoses carries
information about the prevalence of previously un-
diagnosed infections, which is possibly changing
over the course of this one year, depending on the
rate of diagnoses as well as the rate of new infections.
To understand the diagnosis process and establish an
appropriate model for the data, we consider the fol-
lowing assumptions. First, we assume that an individ-
ual i coming for a test on the date t has a test result yi
that can be viewed as a random draw from the
Bernoulli distribution, with some unknown parameter
u(t), dropping temporarily the age and region indices
for ease of presentation. We note that since the VCT
data do not include people who were known to be pre-
viously diagnosed, u(t) does not exactly represent un-
diagnosed prevalence π(t)(1− δ(t)), for which the
denominator population is all MSM, including those
previously diagnosed. However, since the number
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diagnosed represents a small fraction of the total
population, we will assume that u(t) is sufficiently
close to the true undiagnosed prevalence and we will
not make the distinction between these two quantities
i.e.
u(t) = π(t)(1− δ(t))
1− π(t)δ(t) ≈ π(t)(1− δ(t)).
Next, we assume that over the course of one year the
rate of diagnoses in the population rd and the rate of
new infections in the population ri remains constant.
We also assume that the overall population of MSM
is stable over the course of the year, i.e. that entries
and exits to the population (due to aging, migration,
death and behaviour change) cancel. We may then
write:
u(t) = u(t0) + ri(t− t0) − rd(t− t0)
= u(t0) + (ri − rd)(t− t0), (1)
where t∈ [t0, t1], with t0 denoting 1 January 2010 and
t1 denoting 31 December 2010.
We note that due to equation (1), if the number of
diagnoses corresponds to the number of new infec-
tions, then u(t) will not change over time. If this
were the case, a simplifying assumption could be
made that the VCT data may inform u(t) at any
time point in 2010, including at the start of the year
or end of 2009. In order to challenge this assumption
for the interval [t0, t1], we run a binomial regression
model on the VCT data, with outcome the HIV-
positive result and test date as the explanatory
Table 1. Data directly and indirectly informing modelled parameters
Definition Basic or functional parameter Data Source
Proportion of MSM in men aged 515 years ν 35/1536 General population survey
Number of diagnosed HIV cases in MSM (by age,
region)
dage,reg =Nage,reg · ν · πage,reg ·
δage,reg
Number of reported HIV cases in MSM (by age,
region)
μrepage,reg 4 dage,reg Case-based surveillance
μrep435,Maz 77
μrep435,Oth 198
μrep.35,Maz 163
μrep.35,Oth 398
Number of reported HIV cases in MSM or men with
unknown exposure category (by age, region)
μrepage,reg + μunkage,reg 5 dage,reg Case-based surveillance
μrep435,Maz + μunk435,Maz 325
μrep435,Oth + μunk435,Oth 1670
μrep.35,Maz + μunk.35,Maz 564
μrep.35,Oth + μunk.35,Oth 2475
Prevalence of diagnosed infection (by age, region) dpage,reg = πage,reg · δage,reg EMIS survey
dp435,Maz 31/776
dp435,Oth 44/1549
dp>35,Maz 17/188
dp>35,Oth 21/327
Prevalence of undiagnosed infection (by age, region) uage,reg = πage,reg · (1− δage,reg) VCT data
u435,Maz 41/1053
u435,Oth 49/1272
u>35,Maz 18/183
u>35,Oth 28/217
Past 6-month testing rate in previously undiagnosed
(by age, region)
TR435,Maz 216/739 EMIS survey
TR435,Oth 313/1488
TR>35,Maz 28/169
TR>35,Oth 51/298
Prevalence in tested past 6 months, not diagnosed >6
months prior to the survey (by age, region)
p1435,Maz 12/216 EMIS survey
p1435,Oth 4/313
p1.35,Maz 1/28
p1.35,Oth 2/51
EMIS, European MSM Internet Survey; VCT, voluntary counselling and testing.
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variable. No significant trend was noted and the
details of this analysis are presented in the
Supplementary material (Fig. S1, Table S1). We there-
fore concluded that during the year 2010 the undiag-
nosed prevalence remained approximately the same
and the VCT data can be used to inform the undiag-
nosed prevalence at the end of 2009, u(t) = u(t0) = u.
We may therefore specify the contribution of the
VCT data to the likelihood as a series of Bernoulli
trials for each individual with parameter u, or equiva-
lently, the summed positive test results (Table 1)
yVCTage,reg =
∑
i[age,reg yi being drawn from a Binomial
distribution:
yVCTage,regBinomial(nVCTage,reg, uage,reg),
uage,reg = πage,reg(1− δage,reg).
Diagnosed prevalence by age and region. The number
of EMIS respondents self-reporting a diagnosis prior
to the end of 2009, yEMIage,reg (Table 1), was assumed to
be a draw from a Binomial random variable, with de-
nominator the total MSM respondants who answered
the question, nEMIage,reg and probability parameter the
(previously) diagnosed prevalence dpage,reg:
yEMIage,regBinomial(nEMIage,reg, dpage,reg),
dpage,reg = πage,reg · δage,reg,
dage,reg = Nage,reg · ν · dpage,reg,
where dage,reg denotes the total number of diagnosed
cases by age and region and Nage,reg is the total popu-
lation of men aged >18 years by age group and region:
age =435, >35; reg =Maz, Oth. The parameter
dage,reg is additionally informed by the number of
registered cases in the surveillance data by age and re-
gion. However, due to a large proportion of missing in-
formation on the risk group in the surveillance data, we
were not able to use the registered numbers directly. We
assumed that the true number of diagnoses lies between
the reported number of HIV cases among MSM and
the number of male cases reported either as MSM or
with missing transmission category, i.e.
μrepage,reg 4 dage,reg 4 μ
rep
age,reg + μunkage,reg, (2)
and the observed counts yrepage,reg and y
unk
age,reg are mod-
elled as realizations of Poisson distributions with
means of μrepage,reg and μ
unk
age,reg, respectively.
MSM in the general population. The proportion of
men in the general population, npop, who are MSM,
ypop (Table 1), is taken to be a realization of a
Binomial random variable:
ypop: Binomial npop, ν
( )
.
We also define the overall prevalence and overall
diagnosed fraction:
π =
∑
age,reg
Nage,regπage,reg
∑
age,reg
Nage,reg
,
δ =
∑
age,reg
dage,reg
ν
∑
age,reg
Nage,regπage,reg
,
Figure 1 is a directed acyclic graph (DAG) visualiz-
ing the relationships between the data and the par-
ameters in the model. The square nodes represent
observed data; the double circle nodes are parameters
for which a prior distribution is assumed; and the sin-
gle circle nodes are the parameters defined as func-
tions of other parameters. Further, solid arrows
denote stochastic relationships, i.e. the parent nodes
determine the distributions of the child nodes. The
dashed arrows specify deterministic functional rela-
tionships, i.e. that the child node can be expressed as
a function of the parent nodes. The dash-dotted rec-
tangles represent repetition, so that the relationships
inside the inner rectangle are specified separately in
each age/region stratum.
RESULTS
Initial model
Initial model M0 assumes that all data sources provide
unbiased samples from the total population of MSM
in Poland. The summary results of the model are pre-
sented in Table 2. Analysing the model fit, the
deviances for the majority of the data points fall
close to unity, except notably the deviance for data
corresponding to the proportion of MSM in the gen-
eral population of men, ν (Table 2). This observation
indicates potential conflict between the results of this
general population survey and the other data points.
Compared to the observed percentage 100× 35/
1536 = 2·28%, the estimate for ν in this model was
approximately 0·8% (95% CrI 0·5–1·0) (Table 2),
which also stands in conflict with typical estimates
observed in many countries, e.g. [31]. This suggests
that some of the other data may be biased. In add-
ition, we note the large deviance value for the EMIS
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data, suggesting that some lack of fit may in fact con-
cern this dataset.
Bias modelling
Due to uncertainty regarding the effects of allowing
biases in the model, we adopted a stepwise approach
to build in parameters for the potential biases in the
EMIS and VCT data. We suspect that both studies
may include only subsets of the MSM population
with increased risk for infection, i.e. that overall
prevalence (both diagnosed and undiagnosed) is
higher among the study respondents than in the
total population of MSM. Furthermore, we also as-
sume an ordered relationship between age-specific pre-
valences in the source MSM population exists and
that despite the biases, this order is maintained in
the two study populations. The bias models we imple-
ment at each step reflect these prior beliefs.
Model M1: bias in the EMIS data only
We denote the diagnosed prevalence in EMIS respon-
dents by dpEMIage,reg, age =4 35,. 35, reg = Maz,Oth.
The belief that this diagnosed prevalence is greater
than diagnosed prevalence in the general MSM popu-
lation, dpage,reg, is expressed via an odds ratio (OR) for
being diagnosed with HIV in EMIS respondents
relative to the total MSM population, OREMIreg :
logit(dpEMI435,reg) = logit(dp435,reg) + ln(OREMIreg ). (3)
The relationship described by equation (3) is spe-
cified for the younger age group, with diagnosed
prevalence in the older age group being related to
diagnosed prevalence in the younger group via a se-
cond bias parameter, ORagedp,reg:
logit(dpEMI.35,reg) = logit(dpEMI435,reg) + ln(ORagedp,reg), (4)
ln(ORagedp,reg) = logit(dp.35) − logit(dp435). (5)
Equation (5) states that the odds ratio ORagedp,reg
denotes the age-ordered relationship in diagnosed
prevalence, not only in the EMIS respondents, but
also in the total MSM population, i.e. the true age re-
lation is preserved in the EMIS data.
The odds ratios OREMIreg are given a vague prior dis-
tribution (on the log scale) admitting only positive
values, to reflect the belief of higher prevalence in
the EMIS respondents:
ln(OREMIreg ) half −Normal(0, 100),
where half-Normal(0,100) signifies the positive half-
Normal distribution whose corresponding normal
distribution has mean 0 and variance 100.
Fig. 1. Directed acyclic graph of the initial model (see description in the text).
HIV prevalence estimates for MSM, Poland 1181
Table 2. Comparison of basic parameters (median, 95% credible interval) and deviances between the considered models
Estimates under different models
Parameter M0 M1 M2 M3 M4 M5 M6 M7
ν(%) 0·8 (0·5–1) 2·1 (1·4–2·8) 2·1 (1·5–2·9) 2·1 (1·4–2·8) 2·1 (1·4–2·8) 2·1 (1·4–2·8) 2 (1·4–2·8) 2·3 (1·6–3·1)
π(%) 12 (9·7–14·8) 9·9 (7·6–12·5) 6·2 (1·6–11) 2·3 (1·4–3·9) 2·4 (1·4–4·1) 2·8 (1·3–8·3) 3·2 (1·3–9·7) 1·4 (0·9–2·4)
1− δ(%) 76·6 (69·6–82·3) 93·1 (88·9–95·9) 88·9 (58·8–95) 68·3 (59·3–76·1) 69·1 (57·4–79·2) 74·3 (54·2–91·7) 77 (54·2–93·4) 60 (51·2–69)
Number
diagnosed
3353 (2788–3843) 2228 (1513–2800) 2206 (1495–2783) 2394 (1764–2887) 2364 (1680–2874) 2298 (1566–2844) 2284 (1550–2838) 2071
(1424–2654)
Number
undiagnosed
10 970
(7099–16 310)
29 610
(18 890–44 880)
17 550
(3093–37 530)
5063
(3186–8124)
5212
(2921–9230)
2547
(6605–24 420)
7564
(2551–30 000)
3033
(1935–5099)
Bias estimates
Bias in EMIS data
OREMIMaz — 5·4 (2·7–9·8) 5·5 (2·8–9·9) 6·5 (3·8–10·6) 6·2 (3·6–10·4) 5·7 (3·0–10·0) 5·6 (2·9–9·9) 7·1 (3·7–12·5)
OREMIOth — 8·6 (4·4–15·8) 8·8 (4·5–16·1) 6·5 (3·8–10·6) 6·9 (3·9–12·1) 7·6 (4·0–14·4) 7·8 (4·1–14·8) 11·6 (6·1–20·1)
ORagedp,Maz — 1·9 (1–3) 1·9 (1·1–3) 2·0 (1·2–3·2) 2·0 (1·2–3·1) 2·0 (1·1–3·1) 1·9 (1·1–3·1) 2·2 (1·5–3·3)
ORagedp,Oth — 2 (1·2–3·2) 2 (1·2–3·3) 1·8 (1·1–2·8) 1·8 (1·1–3) 1·9 (1·1–3·1) 2·0 (1·1–3·2) 3·0 (2·1–4·3)
Bias in VCT
data
ORVCTMaz — — 1·5 (1–13·1) 6·5 (3·8–10·6) 6·3 (3·4–11·8) 4·7 (1·2–13·8) 3·9 (1–13·6) 7·1 (3·7–12·5)
ORVCTOth — — 1·7 (1–24) 6·5 (3·8–10·6) 6·3 (3·4–11·9) 5·0 (1·2–15·8) 4·4 (1–17·4) 11·6 (6·1–20·1)
ORageu,Maz — — 2·7 (1·5–4·7) 2·7 (1·5–4·7) 2·7 (1·5–4·7) 2·7 (1·5–4·7) 2·7 (1·5–4·7) 2·2 (1·5–3·3)
ORageu,Oth — — 3·7 (2·2–6·0) 3·7 (2·2–6·0) 3·7 (2·2–6·0) 3·7 (2·2–6·0) 3·7 (2·2–5·9) 3 (2·1–4·3)
Posterior deviance contributions
Devν 31·17 1·38 1·29 1·39 1·42 1·43 1·43 0·98
Devdp435,Maz 0·92 0·99 0·98 1·02 0·99 0·97 0·98 1·11
Devdp435,Oth 0·89 0·99 0·98 0·99 0·97 0·97 0·97 1·02
Devdp.35,Maz 6·31 1·33 1·32 0·80 0·85 1·13 1·20 1·05
Devdp.35,Oth 16·22 1·19 1·17 1·95 1·76 1·46 1·41 0·99
Devu435,Maz 0·99 1·00 0·99 0·99 0·98 0·99 0·99 0·91
Devu435,Oth 0·99 1·00 0·99 0·98 0·98 0·99 0·99 2·08
Devu.35,Maz 0·98 0·99 0·99 0·98 0·98 0·98 0·99 1·23
Devu.35,Oth 1·00 1·00 1·01 0·98 0·99 0·99 0·99 1·83
DIC 83·5 34·9 34·8 35·0 34·5 34·9 34·9 69·5 (35·9)
EMIS, European MSM Internet Survey; VCT, voluntary counselling and testing; OR, odds ratio; DIC, Deviance Information Criterion.
M0, Initial model; M1, biased EMIS data; M2, both VCT and EMIS data biased; M3, both VCT and EMIS data biased, bias equal; M4–M6, both VCT and EMIS data
biased, bias coming from the same distribution with increasing variance (c= 0·1, 0·5, 0·8); M7, EMIS nested testing model; Devu, Devdp, for the models accounting for bias,
these deviances refer to the biased data.
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Results. Model M1 has a smaller DIC value than the
initial model M0. We note also that the estimated bias
parameters are important, with a 95% CrI excluding
1: OREMIMaz = 5·4(95% CrI 2·7−9·8), OREMIOth = 8·6
(95% CrI 4·4−15·8). Under this model, the conflict
between the number diagnosed and the combination
of the proportion diagnosed with the MSM popula-
tion size is resolved by reducing the proportion diag-
nosed. This, however, results in an estimated high
fraction of infections undiagnosed (93·1%, 95% CrI
88·9–95·9). The high undiagnosed prevalence is
informed by the assumed unbiased VCT data. The
second-step model (M2) therefore allows the VCT
data to be biased as well.
Model M2: bias in both the EMIS and VCT data
The bias in the VCT data was modelled similarly to
the bias in the EMIS data [equation (3)], assuming a
preserved ordered relationship between age groups
[equation (5)]. We define the biased prevalences of un-
diagnosed infection uVCTage,reg, observed in the VCT data,
again in terms of two bias parameters per region,
ORVCTreg and OR
age
u,reg. These two parameters represent,
respectively: (i) the OR of undiagnosed prevalence in
clients of the VCT sites in comparison to the total
MSM population, for the younger age group, by re-
gion; and (ii) the OR of undiagnosed prevalence in
the older age group relative to the younger, again
taken to be the same in both the VCT data and in
the general population of MSM. We therefore define:
logit(uup435,reg) = logit(u435,reg) + ln(ORVCTreg ), (6)
logit(uup.35,reg) = logit(uup435,reg) + ln(ORageu,reg), (7)
ln(ORageu,reg) = logit(u.35,reg)
− logit(u435,reg), where reg
= Maz,Oth (8)
and the following prior distributions for ORVCTreg ,
where reg =Maz, Oth:
ln(ORVCTreg )  half −Normal(0, 100).
Results. The estimated bias parameters for the VCT
data in the model M2 have credible intervals above
1, but these are very wide. The DIC, overall deviance
and deviance contributions of the particular data
points are small, indicating a relatively good fit of
the model. However, we note a lack of precision in
the estimates for the key parameters, e.g. the estimate
of overall prevalence π has a 95% CrI of 1·6–11·0 and
the corresponding CrI for the undiagnosed fraction
(1− δ) is 58·8–95·0. This could be the effect of allow-
ing too much flexibility in the model. The posterior
distribution of π hints at having two peaks – one for
smaller values and another one at approximately 10%.
Model M3: constrained biases
In consequence, we attempted to reduce the number of
the parameters to be estimated by the model. We did
so by introducing a constraint on the biases, consider-
ing that both the datasets could be similarily biased.
To support this, the estimated biases in the model
M2 had largely overlapping credible intervals and
the two study groups share similar demographic char-
acteristics (Supplementary Table S1). In model M3 we
assumed:
OREMIMaz = OREMIOth = ORVCTMaz = ORVCTOth . (9)
Results and sensitivity analysis. The model M3 has ac-
ceptable deviance estimates and DIC value similar to
the previous models. We obtain also more precise esti-
mates for the overall prevalence and the undiagnosed
fraction, which are both in this model lower than in
the model allowing for bias in the EMIS data only,
with posterior medians of 2·3% vs. 9·9% and 68·3%
vs. 93·1% respectively. We consider that the assump-
tion (9) of the equality of biases is quite strong. In
order to investigate the impact of this assumption on
the model fit, we ran a sensitivity analysis allowing
the biases to come from the same distribution, instead
of being equal. In order to ensure that the ORs are
positive, we assign prior distributions on the square
root scale. We assume:
NameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMe
ORVCTMaz
√
,
NameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMe
ORVCTOth
√
,
NameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMe
OREMIMaz
√
,
NameMeNameMeNameMeNameMeNameMeNameMeNameMeNameMe
OREMIOth
√
Normal(μ, σ2), (10)
where μ is assigned a flat prior:
μ: Normal 0, 100( ),
To test the sensitivity of the results to the distribu-
tion of the biases, σ is assigned a series of priors (mod-
els M4, M5, M6):
σ : Uniform 0, c( ), c [ 0·1, 0·5, 0·8{ }.
We note that when c= 0·1 (model M4), the results
are close to the results of model M3 (assuming strict
equality of biases). On the other hand, in the model
M6 with c= 0·8, the constraint is already too weak
to effect a visible difference from the unconstrained
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model M2. Figure 2 shows the changes in the poster-
ior density curves for the overall prevalence π and the
undiagnosed fraction (1− δ) with increasing flexibility
in the bias modelling. Both parameters are well
defined for the constrained model, and when the con-
straint is relaxed, they become diffuse, accommodat-
ing larger probability of higher values. We observe
that these higher values are consistent with the esti-
mates of the model M1, for which only the EMIS
data are considered biased. We conclude that possibly
the models M1 and M3 constitute two alternative
ways of resolving the conflict in the data, while pre-
serving identifiability of the parameters. Assuming
that the VCT data are not likely to be unbiased, we ac-
cept model M3 as our final model.
Model 7: alternative bias modelling using testing
process data from EMIS
Taking into account the strong assumptions behind
our bias models we additionally explored a different
approach to modeling the information available
through EMIS to see if the results are consistent.
EMIS survey questions allow the testing and diagnosis
process in the last 6 months, i.e. end of 2009 up to the
study time, to be assessed. Under some assumptions,
detailed below, an explicit model of this process may
be used to inform not only the diagnosed prevalence,
but also the prevalence of undiagnosed HIV infec-
tions. First, we will regard the individual records as
coming from two time points: T1, 6 months before
participation in the survey; and T2, the actual date
of the survey. We will distinguish between recent
(within past 6 months) and long-standing HIV diag-
noses, based on the reported date of HIV diagnosis.
This distinction will define the status of HIV diagnosis
at T1 (‘known positive’ in case of long-standing HIV
diagnosis and ‘no HIV diagnosis’ otherwise). The test-
ing process, which takes place between T1 and T2 in
those with no HIV diagnosis at T1 is then captured
through recent testing history (past 6 months) and re-
cent HIV diagnosis (past 6 months), in those recently
tested.
Let us introduce new parameters referring to the
EMIS source population, by age and region:
mEMIage,reg: parameter describing recruitment into EMIS
study,
dpEMIage,reg: diagnosed prevalence at T1,
p1age,reg: prevalence in those tested between T1 and T2,
p2age,reg: prevalence in those not tested between T1 and
T2,
TRage,reg: proportion tested between T1 and T2.
Let us consider a nested binomial model to
describe the diagnosis process between T1 and T2 in
the EMIS source population. This model will be
informed directly by the data observed in the EMIS
survey, assuming that all missing values are missing
at random.
We denote the number of individuals who
responded to EMIS by Mage,reg, of whom y1age,reg
were already diagnosed by T1, y2age,reg were tested
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Fig. 2. Density plots for overall HIV prevalence and the undiagnosed fraction in models with relaxation of the constraint
on bias compared to the density plots for the model with only VCT data biased.
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between T1 and T2, and y3age,reg were diagnosed with
HIV between T1 and T2. Furthermore, x1age,reg,
x2age,reg and x
3
age,reg represent the number of observa-
tions with missing values at each stage.
Mage,reg  Poisson(mEMIage,reg)
y1age,reg  Binomial(Mage,reg − x1age,reg, dpEMIage,reg)
y2age,reg  Binomial((Mage,reg − x1age,reg − y1age,reg)
−x2age,reg,TRage,reg)
y3age,reg  Binomial(y2age,reg − x3age,reg, p1age,reg).
⎫⎪⎪⎪⎪⎪⎬
⎪⎪⎪⎪⎪⎭
(11)
This nested structure is visualized in the DAG in
Figure 3.
To estimate HIV prevalence in those not tested
during the preceding 6 months, p2age,reg, additional
assumptions are necessary. As testing of MSM
is often driven by risky sexual practices we
assumed that the prevelance in those tested is likely
higher than in those not tested. Since no other in-
formation was available, we assumed that
p2age,reg [ (0, p1age,reg].
This assumption leads to the following constraint
on the undiagnosed prevalence in the EMIS source
population, uEMIage,reg, at T1:
uEMIage,reg = TRage,reg · (1− dpEMIage,reg) · p1age,reg
( )
+ 1− TRage,reg
( ) · (1− dpEMIage,reg) · p2age,reg
( )
[ (TRage,reg · (1− dpEMIage,reg) · p1age,reg,
(1− dpEMIage,reg) · p1age,reg).
(12)
This information is included in the model by setting
uniform priors on uEMIage,reg on these intervals. The
prevalence πEMIage,reg and diagnosed fraction δ
EMI
age,reg in
the EMIS source population at the end of 2009 will
be modelled as functions of the parameters introduced
above:
πEMIage,reg = dpEMIage,reg + uEMIage,reg,
δEMIage,reg =
dpEMIage,reg
πage,reg
.
In line with the previously introduced assumptions,
we consider the EMIS population to be biased to-
wards a higher risk subgroup, due to the recruitment
process. Here, we define prevalence in the general
population in terms of prevalence in the EMIS
Fig. 3. Directed acyclic graph of the nested binomial structure in model M7 (see description in the text).
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population and a bias parameter, in contrast to the
bias models (see ‘Bias modelling’ section above),
where we defined the EMIS diagnosed prevalence in
terms of the general population diagnosed prevalence
and a bias parameter.
logit(π435,reg) = logit(πEMI435,reg) − ln(OREMIreg ). (13)
As before, we assume that the age structure, by re-
gion, is preserved.
ln(ORagereg ) = logit(πEMI.35,reg) − logit(πEMI435,reg),
logit(π.35,reg) = logit(π435,reg) + ln(ORagereg ),
A further assumption is that the diagnosed fraction
in the general population is the same as in the EMIS
source population, δage,reg = δEMIage,reg. Last, we also as-
sume that the EMIS source population is similar to
the VCT source population. This assumption is imple-
mented by:
yVCTage,reg  Binomial(nVCTage,reg, uVCTage,reg), (14)
uVCTage,reg = πEMIage,reg · (1− δage,reg). (15)
Since the bias parameters for πEMIage,reg relating them
to the underlying parameter πage,reg are introduced in
multiplicative form [additive on the log scale, equa-
tion (13)], by substituting them into equation (15) we
see that the same biases will apply to uVCTage,reg with re-
spect to the true undiagnosed prevalence uage,reg, i.e.
in this model ORVCTreg = OREMIreg . We note further
that inclusion of the testing process data available in
EMIS, but not in VCT, allowed us to fine tune the
modelling of bias. In M7, we distinguish the bias
due to selection into the study sample defined by equa-
tion (13) and the bias introduced possibly by differ-
ences between MSM who tested within the past 6
months and those not tested during this period, equa-
tion (12).
Results. Deviance estimates for model M7 are at an ac-
ceptable level both for the data informing the diag-
nosed and undiagnosed prevalence estimates (Table 2)
and for the testing proportions (deviances not
shown). Model M7 estimates a slightly lower number
of diagnosed cases than model M3, 2071 vs. 2394,
and a markedly lower number of undiagnosed cases,
3033 vs. 5063. In consequence the undiagnosed fraction
in model M7 is lower, 60·0% (95% CrI 51·2–69·0), than
in model M3, 68·3% (95% CrI 59·3–76·1), but the cred-
ible intervals largely overlap. Although the DIC value
is larger for model M7, it is not directly comparable
to the DIC for model M3, due to the differing and add-
itional EMIS data included in the two models. We can,
however, compare the contributions to the DIC result-
ing from the data that are common to the two models,
namely the risk group proportion data, the diagnosis
registry data and the VCT data. In model M3, these
contributions sum to 34·9, whereas in model M7,
they sum to 35·9. Since these contributions don’t differ
greatly, Model M7 may be considered an acceptable al-
ternative to model M3, particularly as it provides add-
itional information on testing patterns not available
from the previous models.
Regional and age differences: models M3, M7
Both models M3 and M7 demonstrate marked differ-
ences between regions and age groups (Fig. 4).
The prevalence is higher in older MSM. In model
M3 the posterior probability that the prevalence is
higher in MSM aged >35 years than in MSM aged
435 years was P = 0·999 both in Mazowieckie and
other regions. The respective posterior probability
values for model M7 were 0·99 and 0·99. In the
younger group, the prevalence tends to be higher in
Mazowieckie than in other regions (M3: 1·3%, 95%
CrI 0·8–2·3 vs. 1·0%, 95% CrI 0·8–1·8, posterior prob-
ability P = 0·92; M7: 1·2%, 95% CrI 0·7–2·4 vs. 0·6%,
95% CrI 0·3–1·1, posterior probability P = 0·99). The
diagnosed fraction was the highest in younger MSM
in Mazowieckie region, 52·7% (95% CrI 42·1–63·4)
as estimated by model M3 and 53·0% (95% CrI
42·4–63·2) by M7. The posterior probabilities that
the diagnosed fraction is higher in MSM in
Mazowieckie aged 435 years compared to MSM in
Mazowieckie aged >35 years, and MSM in other
regions aged 435 and >35 years are 0·77, 0·92 and
0·99, respectively, in M3 and 0·70, 0·77 and 0·98, re-
spectively, in M7.
Testing proportions could be estimated only from
model M7. Past 6-month testing proportions were
higher in the younger age group, especially in
Mazowieckie, than in the older age group. Of MSM
aged435 years in Mazowieckie (including the capital
region) 32·6% (95% CrI 29·0–36·2) were tested in the
previous 6 months compared to 23·1% (95% CrI
20·9–25·4) of MSM aged 435 in other regions and
20·0% (95% CrI 14·0–27·0) of MSM aged >35 in
Mazowieckie. The respective posterior probabilities
that the proportion tested was higher in MSM aged
435 years in Mazowieckie were both 0·99. The
MSM aged >35, outside Mazowieckie region were
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the least likely to test (19·5%, 95% CrI 15·1–24·5). The
posterior probabilities that the proportion was lower
than in MSM aged 435 in Mazowieckie, aged 435
in other regions, and aged >35 in Mazowieckie were
>0·999, 0·80 and 0·90, respectively.
DISCUSSION
In this study, we investigated the possibility of estimat-
ing HIV prevalence and the fraction of infections that
are undiagnosed in MSM in Poland, using existing evi-
dence from diagnostic testing and behavioural surveys.
Through analysing the conflicts between data and
introducing bias parameters to the model, we were
able to demonstrate that the available data possibly suf-
fer from various biases. However, admitting bias in all
data resulted in an inability to determine the main
parameters of interest with sufficient precision. Only
through imposing a significant constraint on the inter-
relation of biases were we able both to resolve the confl-
icts and to arrive at meaningful estimates.
Considering the family of models where the testing
process was not explicitly modelled, the two models
with satisfactory model fit criteria and good identifia-
bilty are: (1) the model allowing only the internet be-
havioural survey (EMIS) data to be biased (model
M1); (2) the model constraining the biases in the
EMIS and voluntary testing (VCT) data to be equal
0·0
0·2
0·4
0·6
0·8
1·0
Population subgroup (age, region)
Pr
op
or
tio
n 
of
 d
ia
gn
os
ed
 (d
)
≤35,Maz ≤35,Oth >35,Maz >35,Oth
0·00
0·02
0·04
0·06
0·08
0·10
Population subgroup (age, region)
H
IV
 p
re
va
le
nc
e 
(p)
≤35,Maz ≤35,Oth >35,Maz >35,Oth
0·0
0·2
0·4
0·6
0·8
1·0
Population subgroup (age, region)
Pr
op
or
tio
n 
of
 d
ia
gn
os
ed
 (d
)
≤35,Maz ≤35,Oth >35,Maz >35,Oth
0·00
0·02
0·04
0·06
0·08
0·10
Population subgroup (age, region)
H
IV
 p
re
va
le
nc
e 
(p)
≤35,Maz ≤35,Oth >35,Maz >35,Oth
(a)
(b)
Model M3
Model M7
Fig. 4. The prevalence and proportion of diagnosed infections in MSM by age and region in models M3 and M7 (darker
colour represents higher density, median value is marked). (a) Model M3, (b) model M7.
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(model M3) (or, equivalently, drawn from the same
distribution if the distribution has small variance as
in model M4). However, these two models result in
markedly different estimates of the key parameters
of interest. The first one estimates the prevalence to
be 9·9% (95% CrI 7·6–12·5) and the undiagnosed frac-
tion to be 93·1% (95% CrI 88·9–95·9), whereas in the
second model, the prevalence is 2·3% (95% CrI 1·4–
3·9) and the undiagnosed fraction is 68·3·6% (95%
CrI 59·3–76·1). The results of these two models
could be understood as providing two different scen-
arios for the biases in the data, resolving conflicts be-
tween the data sources in two alternative ways. The
first one assumes important bias in the EMIS data,
while trusting that the assumed unbiased VCT data
can resolve the conflict between the observed number
of diagnoses and the population size, together with the
prevalence of diagnosed infection, by reducing this lat-
ter quantity. However, in this scenario, prevalence is
high and therefore the fraction of infections that are
diagnosed is estimated to be very low. The second
scenario, on the other hand, assumes that both the
VCT and the EMIS data are similarily biased. This
proposition is based on the assumption that the source
population for both EMIS and VCT largely overlaps,
indicating that MSM recruited by VCT and EMIS
originate from the same sub-population of MSM,
who may have a higher risk profile than the total
MSM population in Poland. The conflict is then
resolved by estimating lower prevalence to match the
observed number of diagnoses.
Additional information would be necessary to dif-
ferentiate between the two models, since they fit the
data equally well according to the DIC. However,
circumstantial evidence allows us to discuss the plausi-
bility of the models. Crucially, the assumption that
the VCT data might be unbiased is unrealistic.
Self-referred testing is not usually a random process.
Previous studies have found that testing may be
related to risk behaviours. Those with higher risk
practices present for testing more frequently than
those with less risky behaviour, either due to perceived
increased risk of infection or due to onset of symp-
toms of sexually transmitted infections [32–35].
Moreover, the estimated undiagnosed fraction of
over 90% is questionable. While a considerable num-
ber of HIV-infected MSM present late, possibly indi-
cating a large pool of undiagnosed infections, they
constitute only ∼10% of newly diagnosed cases [3].
Additionally, a significant proportion (at least 27%)
of newly diagnosed cases in this group show evidence
of recent infection [36], suggesting, on the contrary,
frequent early diagnosis. These observations could
be compatible with an early phase of an epidemic,
when practically all infected individuals are at early
stages of the disease. However, although HIV trans-
mission between MSM in Poland appears to have
increased in recent years, it has been documented
since the late 1980s. Thus, if over 90% of infections
were undiagnosed, we would expect a higher propor-
tion of late-stage infections in the newly diagnosed
population. Furthermore, in the respondents of the
previous serosurvey of 2004, the undiagnosed fraction
was 40% [12]. In the subsequent period, access to test-
ing and testing promotion has increased: although no
data are available to monitor the achieved coverage, a
large increase of the undiagnosed fraction is unlikely.
We therefore gave preference to the second model
(model M3), with biases in VCT and EMIS data con-
strained to be the same. Similar assumptions (i.e.
equality of biases) were inserted in model M7, in
which more detailed data from the EMIS survey
were included. Of note, the addition of these new
data did not result in conflicting evidence, increasing
confidence that the proposed relationships between
the parameters are plausible.
Importantly both models with the bias constraints
(M3 and M7), with lower undiagnosed fraction, indi-
cate that an important number (5063, 95% CrI
3186-8124 in M3 and 3033, 95% CrI 1935–5099 in
M7), or about 60–70% of MSM living with HIV in
Poland may have in fact been undiagnosed in 2009.
The estimated undiagnosed fraction is higher in
older MSM and outside Mazowieckie (the capital re-
gion). In line with these estimates, we also demonstrate
that the proportion tested in the past 6 months is high-
est in young MSM in Mazowieckie. These findings are
consistent with the fact that the population reached by
the VCT network tends to be young and living in cities.
Testing options for MSM living outside of the main
urban areas of Poland should be reviewed, taking
into consideration the possible stigma associated with
an HIV test in villages and small towns.
By contrast, the estimated overall prevalence is
much lower than we might speculate based on diag-
nostic testing data or the EMIS self-reported HIV sta-
tus data alone. The bias parameters (ORs) for both
datasets, when constrained to be similar in M3, are
estimated to be 6·5 (95% CrI 3·8–10·6), excluding 1,
suggesting significant bias upwards in prevalence in
both sources. The ORs estimated from M7 were
even higher, 7·1 (95% CrI 3·7–12·5) in Mazowieckie
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and 11·6 (95% CrI 6·1–20·1) in other regions, also
with credible intervals excluding 1. In terms of the
EMIS survey, this is in line with what was observed
across different participating countries: the respon-
dents tended to be younger and reported HIV more
frequently then expected based on other estimates
[29]. Importantly, this suggests that both the internet
channels used to recruit EMIS participants and the
testing services attract the higher risk MSM subgroup.
On one hand, this opens a window of opportunity to
address prevention messages to those who need them
the most, but on the other hand, this conclusion should
stimulate discussion and design of interventions
targeted towards individuals taking less risk, but still
potentially infected and undiagnosed. These interven-
tions may not necessarily have the same focus as the
ones selected for the subgroup most at risk.
We note that there is little evidence of any differ-
ence between regions in the estimated prevalence for
MSM aged >35 years (posterior probability that
prevalence is higher in Mazowieckie is only P= 0·47
in M3 and P= 0·08 in M7). Although there are no be-
havioural data to explain such a finding, this is con-
sistent with the surveillance data. The number of
new HIV diagnoses in MSM was similar in
Mazowieckie (including Warsaw) to other regions up
to approximately 2002 [3]. It is plausible that the
older age group was not as highly affected by out-
breaks occurring in mid-2000, especially in the capital
region, and thus the prevalence remains similar.
Our study was limited by the data availability and
quality, forcing us to model additional uncertainty
in almost all data sources included, via bias modelling.
The sensitivity analysis led to the understanding that
additional information (either as model constraints,
or ideally, more and/or better quality data) is neces-
sary in order to maintain good identifiability of the
parameters. When relaxing the constraint on the
biases in the model (increasing the parameter, c, deter-
mining the variance of the distribution of the biases)
we notice that there exists a range of values of this par-
ameter for which a transition is noticeable, between
the two alternative scenarios.
Subsequently, and given the equal goodness of fit of
the models, we favoured the model which gave more
plausible results epidemiologically. We acknowledge
that by imposing the constraint on the biases, we
made a strong assumption on the interrelation of the
data sources. Specifically, as discussed above, we
assumed that data informing diagnosed and undiag-
nosed prevalence came from a similar population.
Moreover, individual testing decisions may depend
on multiple factors. In particular, those factors may
depend on age, which would compromise our assump-
tion that age differences of prevalence in the general
MSM population are preserved also in the testers.
The results should be therefore interpreted with
caution.
Drawing robust conclusions regarding the epi-
demiological situation ideally requires collecting add-
itional good quality data, including bio-behavioural
surveys. The existing data sources could be explored
for potential modelling of completeness of case-based
surveillance data, in order to obtain a more precise es-
timate of the number diagnosed. Additionally, if more
disaggregated behavioural data were to become avail-
able, the model could include a more comprehensive
approach to bias adjustment, improving our under-
standing of the coverage of the data sources used.
This said, we conclude that even with imperfect and
scarce data at hand, we were able to provide some new
insights into the problem of HIV in the MSM popula-
tion in Poland, by formally combining the available
information and prior knowledge of data collection
systems.
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